Serum levels of cytokines in chronic liver diseases

Gastroenterology

Volumn 103, Issue 1, 1992, Pages 264-274

  Tilg, Herbert ^a,b   Wilmer, Axel ^a,b   Vogel, Wolfgang ^a,b   Herold, Manfred ^a,b   Nölchen, Birgit ^a,b   Judmaier, Gert ^a,b   Huber, Christoph ^a,b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNITY; BILIARY CIRRHOSIS; BLOOD SAMPLING; CHILD; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSIS; DISEASE ACTIVITY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PRIORITY JOURNAL;

ADOLESCENT; ADULT; C-REACTIVE PROTEIN; CHILD; CHRONIC DISEASE; COMPARATIVE STUDY; CYTOKINES; FEMALE; HUMAN; LIVER DISEASES; MALE; MIDDLE AGE; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T;

EID: 0026691627     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(92)91122-K     Document Type: Article

References (57)

1. The cytokine network
2. Interleukin-1 and interleukin-1 antagonism
3. Peptide regulatory factors in non-malignant disease
4. Interleukins and the immune system 2
5. The biology of cachectin/TNF—A primary mediator of the host response
6. Tumor Necrosis Factor. New insights into the molecular mechanisms of its multiple actions
7. Interleukin-6: an overview
8. Cytokines: coordinators of immune and inflammatory responses
9. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: Role in the induction of interleukin 6
10. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways
11. Biologically active products of stimulated liver macrophages (Kupffer cells)
12. Effects of cytokines on the liver
13. Virus-vs endotoxin-induced activation of liver macrophages
14. Bacterial endotoxins and the liver
15. Intestinal endotoxins as mediators of hepatic injury—An idea whose time has come again
16. Endotoxemia, encephalopathy, and mortality in cirrhotic patients
17. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis
18. Endotoxemia in liver disease—time for re-appraisal?
19. Tumor necrosis factor: The acute phase response and the pathogenesis of alcoholic liver disease
20. Tumor necrosis factor in alcoholic hepatitis
21. Therapeutic strategies for hepatic fibrosis
22. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue
23. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy
24. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis
25. Serum levels of α-interferon and gamma-interferon in patients with acute and chronic viral hepatitis
26. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production
27. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients
28. Soluble interleukin-2 receptor and soluble CD 8 in liver cirrhosis and obstructive jaundice
29. Soluble interleukin-2 receptor in acute viral hepatitis and chronic liver disease
30. Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease
31. Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma
32. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection
33. Tumor necrosis factor α production by peripheral blood mononuclear cells of patients with chronic liver disease
34. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis
35. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis
36. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection
37. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
38. Transection of the oesophagus for bleeding oesophageal varices
39. NIH conference: Primary biliary cirrhosis: a model autoimmune disease
40. The cellular pathology of primary biliary cirrhosis
41. A classification of chronic hepatitis
42. Structure and variation of human α-1 antitrypsin
43. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
44. In-vitro production of TNF-α in blood samples
45. In-vitro production of cytokines
46. Molecular mechanisms of signal transduction in macrophages
47. Stimulation of ACTH release by human interleukin-1β but not interleukin-1α, in conscious, freely moving reats
48. Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides
49. IgA triggers tumor necrosis factor alpha secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis
50. Mechanism of immune complex-mediated damage: induction of interleukin-1 by immune complexes and synergy with interferongamma and tumor necrosis factor-alpha
51. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat
52. Dissociation between interleukin-1b mRNA and protein synthesis in human peripheral blood mononuclear cells
53. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay
54. The role of tumor necrosis factor (cachectin) in cachexia
55. Evidence of different effects of soluble TNF-receptors on various TNF measurements in human biological fluids
56. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway